Cargando…

Case report: A report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy

Cholangiocarcinoma (CCA) is a rare disease with poor prognosis, and surgery remains the only curative treatment option. However, surgery is inappropriate for the majority of patients with CCA. Conversion therapy may provide opportunities for the surgical treatment of these patients. Herein, we descr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Tang, Hao, Fan, Jun, Wang, Rui, Han, Yunwei, Su, Song, Gan, Yu, Peng, Fangyi, Rao, Mingyue, Zhang, Jianwen, Li, Bo, Yang, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816130/ https://www.ncbi.nlm.nih.gov/pubmed/36618353 http://dx.doi.org/10.3389/fimmu.2022.1051130

Ejemplares similares

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
por: Zhang, Wei, et al.
Publicado: (2023)

Case Report: Camrelizumab combined with gemcitabine and oxaliplatin in the treatment of advanced intrahepatic cholangiocarcinoma: a case report and literature review
por: Zhang, Zhongyan, et al.
Publicado: (2023)

M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma
por: Yang, Long, et al.
Publicado: (2023)

PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature
por: Wang, Zhihong, et al.
Publicado: (2021)

Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
por: Zhang, Zhuochao, et al.
Publicado: (2023)

Intraoperative Conversion to ALPPS in a Case of Intrahepatic Cholangiocarcinoma
por: Oldhafer, F., et al.
Publicado: (2015)

Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
por: Schlinkert, Richard T., et al.
Publicado: (1992)

Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis
por: Sun, Bao-Ye, et al.
Publicado: (2022)

CD86(+)/CD206(+) tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
por: Sun, Dalong, et al.
Publicado: (2020)

Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review
por: Zhang, Ning, et al.
Publicado: (2018)

PD-1 blockade and radiotherapy combination for advanced Epstein-Barr virus-associated intrahepatic cholangiocarcinoma: a case report and literature review
por: Liao, Chun-Xu, et al.
Publicado: (2023)

Pathological Clavicle Fracture: Initial Presentation of Intrahepatic Cholangiocarcinoma
por: Başdelioğlu, Koray
Publicado: (2020)

Laparoscopic hepatopancreatoduodenectomy for synchronous intrahepatic and extrahepatic cholangiocarcinoma: A case report
por: Wu, Bo, et al.
Publicado: (2023)

Intrahepatic Sarcomatous Cholangiocarcinoma: Case Report and Review of the Literature
por: Boonsinsukh, Thana, et al.
Publicado: (2018)

Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case Report
por: Kobayashi, Ryoichiro, et al.
Publicado: (2021)

Case Report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma
por: Liu, Fei, et al.
Publicado: (2023)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
por: Fu, Qiang, et al.
Publicado: (2022)

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)

Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
por: Chung, Taek, et al.
Publicado: (2022)

Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report
por: Zhang, Ze, et al.
Publicado: (2021)

Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel
por: Li, Xiaocheng, et al.
Publicado: (2022)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review: Erratum
Publicado: (2018)

A case report of rectal adenocarcinoma with intrahepatic cholangiocarcinoma of the liver
por: Guo, Jing-qiang, et al.
Publicado: (2019)

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report
por: Guida, Claudio Carmine, et al.
Publicado: (2023)

Intrahepatic cholangiocarcinoma is more complex than we thought: A case report
por: Zeng, Jian-Ting, et al.
Publicado: (2021)

Case Report: Successful conversion and salvage resection of huge hepatocellular carcinoma with portal vein tumor thrombosis and intrahepatic metastasis via sequential hepatic arterial infusion chemotherapy, lenvatinib plus PD-1 antibody followed by simultaneous transcatheter arterial chemoembolization, and portal vein embolization
por: Luo, Xin, et al.
Publicado: (2023)

Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review
por: Xie, Peiyi, et al.
Publicado: (2022)

Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in a Patient With Metastatic Intrahepatic Cholangiocarcinoma With High Tumor Mutational Burden
por: Abudalou, Mohammad, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
por: Xian, Feng, et al.
Publicado: (2023)

Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection
por: Zhang, Mei‐xia, et al.
Publicado: (2018)

Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
por: Zeng, Tian-mei, et al.
Publicado: (2022)

A2M is a potential core gene in intrahepatic cholangiocarcinoma
por: Zhang, Guanran, et al.
Publicado: (2022)

Development and validation of a new prognostic immune–inflammatory–nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study
por: Zhu, Jiang, et al.
Publicado: (2023)

Primary hepatic tuberculosis mimicking intrahepatic cholangiocarcinoma: report of two cases
por: Park, Jeong-Ik
Publicado: (2015)

Intrahepatic cholangiocarcinoma in a patient with Wilson’s disease: a case report
por: Mukai, Yosuke, et al.
Publicado: (2016)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mr09js2339i36uoip4pt2m43rn